Echoliv

Echoliv, a Paris-based MedTech startup established in 2021, is focused on developing artificial intelligence solutions for abdominal ultrasound. The company's primary mission is to assist radiologists and hepatologists in the early detection of liver cancer. Echoliv was co-founded by Elsa Angelini and Victor Neuillet. Neuillet's entrepreneurial journey began at age 20 with various e-commerce ventures, which provided him with a self-taught business education before he pursued projects with more personal meaning, such as eco-responsible clothing lines. This path eventually led him to co-found Echoliv, driven by a desire to advance medicine and improve patient outcomes.

The company operates in the HealthTech, AI, and biotechnology sectors, targeting healthcare providers like radiologists and hepatologists as its primary clients. Echoliv's business model centers on its flagship software, Ultraliv™, an AI-powered tool designed to enhance the accuracy of ultrasound screening for hepatocellular carcinoma, the most common type of liver cancer. The software processes ultrasound images and utilizes algorithms to identify nodules that might be missed by the human eye, thereby aiding in earlier and more accurate diagnoses. This technology also includes features for report writing and data analysis.

Echoliv's development has been supported by its incubation at Station F, a major French startup campus, through their "founders' program." The company is also backed by the IMT Starter incubator. Financially, Echoliv secured a grant of $106K in September 2021 and a pre-seed investment of €60.00K in July 2022 from WILCO. To further refine its AI, the company is collaborating with several university hospitals to access more data and enrich its algorithm. According to PitchBook, the company's status was listed as 'Out of Business' as of June 30, 2023.

Keywords: medical imaging, AI diagnostics, liver cancer detection, ultrasound software, HealthTech, MedTech, radiology AI, hepatology tools, artificial intelligence in healthcare, abdominal ultrasound, Ultraliv, hepatocellular carcinoma screening, medical software, clinical decision support, diagnostic assistance, digital health, oncology AI, early cancer detection, AI algorithms for imaging, biotech